Valuation
- Market cap
- 12,982,000
- Revenue TTM
- $23,340,000
- Net income TTM
- $-101,270,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -433.89%
- Debt to equity
- -1.01
Trading
- Volume
- 1,166,700
- Avg volume
- 7,403,886
- Day's range
- $3.56 – $3.94
- Shares out
- 3,198,000
- Stochastic %K
- 28%
- Beta
- -3.60
- Analysts
- Strong Buy
- Price target
- $18.74
Company profile
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubR...
Show more
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services. DataMEDS AI, Inc., through its subsidiary develops and delivers a portfolio of products to guide physicians and patients with difficult clinical decisions throughout the cancer care continuum. In addition, the company develops and provides functional precision medicine oncology platform. The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.
- Industry
- Medical Distribution
- Sector
- Healthcare
- Phone
- 844 203 6092
- Website
- https://datamedsai.com
- Address
- 3000 Bayport Drive, Suite 950, Tampa, United States
Latest news
No headlines yet.
